Drug General Information
Drug ID	D08LJJ
Former ID	DNC011737
Drug Name	6-Bromo-2-(2-nitro-phenyl)-chromen-4-one
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[551336]
Structure		Download 2D MOL 3D MOL
Formula	C15H8BrNO4
Canonical SMILES	C1=CC=C(C(=C1)C2=CC(=O)C3=C(O2)C=CC(=C3)Br)[N+](=O)[O-]
InChI	1S/C15H8BrNO4/c16-9-5-6-14-11(7-9)13(18)8-15(21-14)10-3-1-2-4-12(10)17(19)20/h1-8H
InChIKey	GXUSNZYZTBJMIT-UHFFFAOYSA-N
PubChem Compound ID	44298955
Target and Pathway
Target(s)	Gamma-aminobutyric acid receptor subunit alpha-1	Target Info	Inhibitor	[551336]
	Gamma-aminobutyric acid receptor	Target Info	Inhibitor	[551336]
KEGG Pathway	Neuroactive ligand-receptor interaction
	Retrograde endocannabinoid signaling
	GABAergic synapse
	Morphine addiction
	Nicotine addiction
Reactome	Ligand-gated ion channel transport
	GABA A receptor activation
WikiPathways	SIDS Susceptibility Pathways
	Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell
	Iron uptake and transport
References
Ref 551336	6-Bromo-3??nitroflavone, a new high affinity benzodiazepine receptor agonist recognizes two populations of cerebral cortical binding sites, Bioorg. Med. Chem. Lett. 7(3):373-378 (1997).
Ref 551336	6-Bromo-3??nitroflavone, a new high affinity benzodiazepine receptor agonist recognizes two populations of cerebral cortical binding sites, Bioorg. Med. Chem. Lett. 7(3):373-378 (1997).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.